Abstract: A bite-block for protecting the mouth of a patient receiving electroconvulsive therapy includes a U-shaped frame made from a unitary piece of a flexible material, such as expanded polyethylene foam, having a first side and an opposite second side. The U-shaped frame includes a body portion and two spaced-apart lobes extending therefrom. The two lobes define a gap therebetween. A force absorbing pad extends upwardly from the first side along at least a portion of each of the two lobes. A handle portion may be added so that the frame is Y-shaped.

Abstract: The invention provides a pharmaceutical composition for treating performance anxiety and social phobia comprising a therapeutic amount for the treatment of a patient of a .beta.-adrenergic receptor blocking compound and an anti-diaphoretic compound. The preferred .beta.-adrenergic receptor blocking compound is the lipophilic .beta.-blocker propranolol HCL. The anti-diaphoretic compound of the present invention is preferably glycopyrrolate. The composition for treating performance anxiety and social phobia can further include a pharmaceutically acceptable carrier. A method of preventing or treating performance anxiety or social phobia in a patient comprising administering the composition of the invention to a patient in need of such treatment is also provided. The composition administered in the present method comprises a therapeutic amount of a .beta.-adrenergic receptor blocking compound and an anti-diaphoretic compound.